...
首页> 外文期刊>BMJ Open >Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial
【24h】

Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial

机译:立体定向放射疗法联合S-1并随后依次进行S-1作为局部晚期胰腺癌(SILAPANC)试验的初始治疗的安全性和有效性:II期临床试验的研究设计和原理

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Abstract Introduction Upfront surgeries are not beneficial to most patients with pancreatic cancer. Therefore, more emphasis has been placed chemoradiotherapy in locally advanced pancreatic cancer recently. Gemcitabine-based regimens or FOLFIRINOX (a chem
机译:摘要简介前期手术对大多数胰腺癌患者无益。因此,近来放化疗已经被更多地用于局部晚期胰腺癌。基于吉西他滨的方案或FOLFIRINOX(化学

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号